Inter- and intramolecular epitope spreading in equine recurrent uveitis

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 2, 2006, Pages 652-656

  Deeg, Cornelia A ^a   Amann, Barbara ^a   Raith, Albert J ^a   Kaspers, Bernd ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; RETINA S ANTIGEN; AUTOANTIBODY; AUTOANTIGEN; PEPTIDE FRAGMENT; RETINOL BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD; BLOOD SAMPLING; CELL PROLIFERATION; CONTROLLED STUDY; HORSE; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; UVEITIS; ANIMAL; ANIMAL DISEASE; ANIMAL MODEL; HORSE DISEASE; IMMUNOLOGY; IRIDOCYCLITIS; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ARRESTIN; AUTOANTIBODIES; AUTOANTIGENS; EPITOPES; HORSE DISEASES; HORSES; LYMPHOCYTE ACTIVATION; MODELS, ANIMAL; PANUVEITIS; PEPTIDE FRAGMENTS; RECURRENCE; RETINOL-BINDING PROTEINS; T-LYMPHOCYTES; UVEITIS, ANTERIOR;

EID: 33644849984     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0789     Document Type: Article

References (28)

1. Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 1998;279:1344-1347.
2. Horwitz MS, Bradley LM, Harbertson J, et al. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med. 1998;4:781-785.
3. Miller SD, Vanderlugt CL, Begolka WS, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med. 1997;3:1133-1136.
4. Vanderlugt CJ, Miller SD. Epitope spreading. Curr Opin Immunol. 1996;8:831-836.
5. Wacker WB, Donoso LA, Kalsow CM, Yankeelov JA Jr, Organisciak DT. Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol. 1977;119:1949-1958.
6. Caspi RR, Roberge FG, Chan CC, et al. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol. 1988;140:1490-1495.
7. Gery I, Wiggert B, Redmond TM, et al. Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Invest Ophthalmol Vis Sci. 1986;27:1296-1300.
8. de Smet MD, Chan CC. Regulation of ocular inflammation: what experimental and human studies have taught us. Prog Retin Eye Res. 2001;20:761-797.
9. Wildner G, Thurau SR. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol. 1994;24:2579-2585.
10. Wildner G, Thurau SR. Database screening for molecular mimicry. Immunol Today. 1997;18:252.
11. Dick AD, Forrester JV, Liversidge J, Cope AP. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). Prog Retin Eye Res. 2004;23:617-637.
12. de Smet MD, Bitar G, Mainigi S, Nussenblatt RB. Human S-antigen determinant recognition in uveitis. Invest Ophthalmol Vis Sci. 2001;42:3233-3238.
13. Tuohy VK, Kinkel RP. Epitope spreading: a mechanism for progression of autoimmune disease. Arch Immunol Ther Exp (Warsz). 2000;48:347-351.
14. Deeg CA, Thurau SR, Gerhards H, et al. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease. Eur J Immunol. 2002;32:2598-2606.
15. Deeg CA, Ehrenhofer M, Thurau SR, et al. Immunopathology of recurrent uveitis in spontaneously diseased horses. Exp Eye Res. 2002;75:127-133.
16. Deeg CA, Kaspers B, Gerhards H, et al. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Invest Ophthalmol Vis Sci. 2001;42:393-398.
17. Werry H, Gerhards H. The surgical therapy of equine recurrent uveitis [in German]. Tierarztl Prax. 1992;20:178-186.
18. Dorey C, Cozette J, Faure JP. A simple and rapid method for isolation of retinal S antigen. Ophthalmic Res. 1982;14:249-255.
19. Donoso LA, Merryman CF, Shinohara T, et al. S-antigen: identification of the MAbA9-C6 monoclonal antibody binding site and the uveitopathogenic sites. Curr Eye Res. 1986;5:995-1004.
20. Gregerson DS, Fling SP, Obritsch WF, Merryman CF, Donoso LA. Identification of T cell recognition sites in S-antigen: dissociation of proliferative and pathogenic sites. Cell Immunol. 1989;123:427-440.
21. Sanui H, Redmond TM, Hu LH, et al. Synthetic peptides derived from IRBP induce EAU and EAP in Lewis rats. Curr Eye Res. 1988;7:727-735.
22. Levin J, Tomasulo PA, Oser RS. Detection of endotoxin in human blood and demonstration of an inhibitor. J Lab Clin Med. 1970;75:903-911.
23. Yu M, Johnson JM, Tuohy VK. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J Exp Med. 1996;183:1777-1788.
24. Tuohy VK, Yu M, Yin L, et al. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev. 1998;164:93-100.
25. Ott PA, Dittrich MT, Herzog BA, et al. T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading. J Clin Immunol. 2004;24:327-339.
26. Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel RP. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med. 1999;189:1033-1042.
27. Goebels N, Hofstetter H, Schmidt S, et al. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain. 2000;123:508-518.
28. Marker-Hermann E, Meyer zum Buschenfelde KH, Wildner G. HLAB27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis. Arthritis Rheum. 1997;40:2047-2054.